Further investment in Embark
Further investment in Embark
Perth, Nov 12, 2018 AEST (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) ("MMJ") is pleased to announce that it has invested CAD$2.5 million of equity into privately-held Embark Health Inc ("Embark"). This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%*.

MMJ's CEO Jason Conroy commented that "We are delighted by the opportunity to make a significant follow-on investment in Embark to support Bruce Dawson-Scully and his experienced management team in developing the quintessential cannabis extraction facility to service Canadian and global medical and recreational markets."

For further information on Embark, please visit:
http://embarkhealthinc.com


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

   


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



Related Companies

MMJ Group Holdings Ltd   

ABN Newswire This Page Viewed:  (Last 7 Days: 67) (Last 30 Days: 684) (Since Published: 1461) 
ANALYTICS: LOGIN HERE

MMJ Group Holdings Ltd NEWS: RECENT VISITS (46109)

Research Report

Social Media